Marksans Pharma has announced an extension of a special window for shareholders to re-lodge transfer deeds for physical shares. This initiative, prompted by SEBI’s circular, allows investors who purchased or sold shares prior to April 1, 2019, and faced issues with transfer document lodgment, to rectify them. The extended window is active for one year, from February 5, 2026, to February 4, 2027.
Special Window for Share Transfers
Marksans Pharma Ltd. is providing a special window for shareholders to re-lodge transfer deeds related to physical shares. This initiative is in response to a circular from SEBI, extending a facility to facilitate the transfer of shares purchased or sold prior to April 1, 2019, where lodgment was previously rejected, returned, or not attended to due to documentation deficiencies.
Eligibility and Process
The special window is open for a period of one year, commencing on February 5, 2026, and concluding on February 4, 2027. Shareholders holding physical shares acquired before April 1, 2019, who have not yet completed the transfer process, are encouraged to utilize this opportunity. They must re-lodge their transfer deeds along with the original share certificates and other required documentation.
Documentation Requirements
To re-lodge transfer deeds, transferees must submit the following:
- Original share certificate.
- Transfer deed executed prior to April 1, 2019.
- Proof of purchase by the transferee.
- KYC documents of the transferee.
- Latest Client Master List of the transferee’s demat account.
- An undertaking cum indemnity as per the prescribed format.
- Any other documents as may be required.
Important Notes
It is important to note that upon successful transfer, shares will be credited to the transferee’s demat account only; no physical certificates will be re-issued. The shares credited will be under a lock-in period of one year from the date of registration. Cases involving court disputes or shares transferred to IEPF will not be processed under this window.
Contact Information
Shareholders can contact the Company’s Registrar and Share Transfer Agent, Bigshare Services Private Limited, at Office No. S6-2, 6th Floor, Pinnacle Business Park, Andheri (East), Mumbai – 400093, or call 022 62638200. Queries can also be emailed to [email protected]. For further assistance, shareholders may contact Marksans Pharma at [email protected] or Mr. Atul Shukla on 022 4001 2000.
Source: BSE
